Skip to main content

Lusk Eye Specialists to Offer OptiLight IPL for Advanced Dry Eye Relief

Shreveport, LA — In an effort to enhance its array of eye care solutions, Lusk Eye Specialists is proud to announce its Dr. Pamela Theriot is now offering patients the option of OptiLight IPL (intense pulsed light) therapy for dry eye symptoms. OptiLight IPL is a revolutionary treatment designed to offer relief to patients suffering from dry eye syndrome. This cutting-edge technology, which is now available at Lusk Eye Specialists in Shreveport, marks an expansion in their comprehensive eye care and aesthetic services.

OptiLight IPL therapy, an innovative approach to treating dry eye disease caused by meibomian gland dysfunction (MGD), is now a part of Lusk Eye Specialists’ extensive treatment offerings. This addition underscores the practice's commitment to integrating the latest advancements in eye health and patient wellness.

Woman receiving OptiLight treatment at Lusk Eye Specialists - Shreveport

“We are thrilled to offer OptiLight IPL therapy alongside our extensive range of dry eye treatments,” said Dr. Pamela Theriot, who leads Lusk Eye Specialists’ dry eye treatment team. “This technology represents a significant leap forward in our ability to provide tailored, effective solutions for our patients suffering from dry eye symptoms. OptiLight IPL therapy complements our commitment to excellence in eye care, offering a non-invasive option that addresses the root cause of dry eye.”

OptiLight by Lumenis is the first and only IPL device that is FDA approved specifically for the management of dry eye disease due to MGD, a common condition that affects millions worldwide. By targeting the inflammation that contributes to the disease, OptiLight IPL therapy helps restore normal gland function and improve tear quality, offering patients long-term relief.

“OptiLight IPL therapy is a game-changer for patients who have struggled with persistent dry eye symptoms,” said Dr. Theriot. “Not only does it provide a significant reduction in discomfort, but it also offers aesthetic benefits, enhancing the skin's appearance around the eyes. Our patients have been delighted with the dual outcomes of improved eye comfort and cosmetic enhancement. It’s a win-win situation.”

The decision to incorporate OptiLight IPL therapy into Lusk Eye Specialists’ service offerings was motivated by a desire to address a broader spectrum of patient needs, from traditional eye care to advanced aesthetic treatments. The introduction of OptiLight is a testament to Lusk Eye Specialists’ forward-thinking approach and dedication to embracing technologies that elevate patient care.

Lusk Eye Specialists is now scheduling consultations for patients interested in exploring how OptiLight IPL therapy can improve their quality of life by effectively managing dry eye symptoms and enhancing ocular aesthetics. The addition of this service is part of Lusk Eye Specialists' ongoing effort to provide the most advanced, comprehensive eye care available in the Ark-La-Tex region. To schedule an appointment, visit https://www.luskeye.com/.

About Lusk Eye Specialists

More than three decades ago, Dr. James Lusk founded Lusk Eye Specialists as a family practice created for families in Ark-La-Tex. Led by Dr. James Lusk and his two knowledgeable sons, Dr. Jeffrey Lusk and Dr. Bryan Lusk, Lusk Eye Specialists goes above and beyond to embrace a welcoming environment patients can trust.

Not only has Dr. James Lusk performed LASIK vision correction surgery on both of his sons, but Dr. Bryan Lusk and Dr. Jeffrey Lusk have also performed their father’s cataract surgery. The three industry-leading surgeons now lead the practice together as specialists in LASIK and cataract surgery.

To learn more about Lusk Eye Specialists and their specialties, visit https://www.luskeye.com/.

###

For more information about Lusk Eye Specialists, contact the company here:

Lusk Eye Specialists
Dr. James E. Lusk
318-284-5550
jimmyhale@luskeye.com
451 Ashley Ridge Blvd,
Shreveport, LA 71106

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.